Want to take quizzes and track your credits?
Many policy makers believe that shelter-in-place or stay-at-home policies could cause an increase in what are known as deaths of despair. While increases in psychiatric stressors during the coronavirus disease 2019 (COVID-19) pandemic have been reported, it is presently unknown whether suicide rates similarly changed during stay-at-home periods.1,2
Sign in to take quiz and track your certificates
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Accepted for Publication: November 21, 2020.
Published: January 21, 2021. doi:10.1001/jamanetworkopen.2020.34273
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Faust JS et al. JAMA Network Open.
Corresponding Author: Jeremy Samuel Faust, MD, MS, Division of Health Policy and Public Health, Department of Emergency Medicine, Brigham and Women’s Hospital, Harvard Medical School, 10 Vining St, Boston, MA 02115 (firstname.lastname@example.org).
Author Contributions: Dr Faust had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Faust, Shah, Lin, Krumholz.
Acquisition, analysis, or interpretation of data: Faust, Du, Li, Lin.
Drafting of the manuscript: Faust, Shah, Li.
Critical revision of the manuscript for important intellectual content: Faust, Du, Lin, Krumholz.
Statistical analysis: Faust, Du, Li, Lin.
Administrative, technical, or material support: Shah.
Supervision: Faust, Li, Lin.
Conflict of Interest Disclosures: Dr Lin reported having a contract with the Centers for Medicare & Medicaid services to develop quality measures. Dr Krumholz reported receiving personal fees from UnitedHealth, IBM Watson Health, Element Science, Aetna, Facebook, Siegfried and Jensen Law Firm, Arnold and Porter Law Firm, Martin/Baughman Law Firm, F-Prime, and the National Center for Cardiovascular Diseases, Beijing; being cofounder of HugoHealth, a personal health information platform, and of Refactor Health, an enterprise healthcare artificial intelligence–augmented data management company; having contracts with the Centers for Medicare & Medicaid Services, through Yale New Haven Hospital, to develop and maintain measures of hospital performance; and receiving grants from Medtronic, the US Food and Drug Administration, Johnson and Johnson, and Shenzhen Center for Health Information outside the submitted work. No other disclosures were reported.
Additional Contributions: The authors wish to thank the Registry of Vital Records and Statistics, Office of Population Health, Massachusetts Department of Public Health for assistance with data acquisition.
You currently have no searches saved.
You currently have no courses saved.